Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice

Journal of Cardiac Failure

Volumn 3, Issue 2, 1997, Pages 117-124

  Kubota, Toru ^a   McTiernan, Charles F ^a,b   Frye, Carole S ^a   Demetris, A Jake ^a   Feldman, Arthur M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha myosin heavy chain promoter; Enzyme linked immunosorbent assay; Proinflammatory cytokine; Reverse transcriptase polymerase chain reaction

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HEART MUSCLE; LIVER; LUNG; METABOLISM; MOUSE; MYOCARDITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; LIVER; LUNG; MICE; MICE, TRANSGENIC; MYOCARDITIS; MYOCARDIUM; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031159090     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90045-2     Document Type: Article

References (48)

1. Tracey KJ, Vlassara H, Cerami A: Cachectin/tumor necrosis factor. Lancet 1989;1:1122-6
2. Vilcek J, Lee TH: Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991;266:7313-6
3. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-6
4. Chollet-Martin S, Depoix JP, Hvass U, Pansard Y, Vissuzaine C, Gougerot-Pocidalo MA: Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant Proc 1990;22:283-6
5. Maury CPJ, Teppo AM: Circulating tumor necrosis factor-α (cachectin) in myocardial infarction. J Intern Med 1989; 225:333-6
6. Latini R, Bianchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, Maggioni AP, Mengozzi M, Romano S, Sharpiro L, Sironi M, Tognoni G, Turato R, Ghezzi P: Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol 1994;23:1-6
7. Levine B, Kalman J, Maycr L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;223:236-41
8. McMurray J, Abdullah I, Dargie HJ, Shapiro D: Increased concentrations of tumor necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991;66:356-8
9. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris G: Tumor necrosis factor α in severe congestive cardiac failure. Br Heart J 1993;70:141-3
10. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL: Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-6
11. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS: Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 1992;90:389-98
12. Eichenholz PW, Eichacker PQ, Hoffman WD, Baanks SM, Parrilo JE, Danner RL: Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol 1992;263:H668-75
13. Murray DR, Freeman GL: Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996;78:154-60
14. Suffredini AF, Fromm RE, Parker MM, Grenner M, Kovacs JA, Wesley RA, Parrillo JE: The cardiovascular response to the administration of endotoxin. N Engl J Med 1989;321: 280-7
15. Hegewisch S, Weh HJ, Hossfeld DK: TNF-induced cardiomyopathy. Lancet 1990;335:294-5
16. Smith SC, Allen PM: Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res 1992;70:856-63
17. Yamada T, Matsumori A, Sasayama S: Therapeutic effect of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994;89:846-51
18. Shrenga M, de Bruin RWF, Jeekel II, Marquet RL: Antitumor necrosis factor alpha serum prolongs heart allograft survival in rats transplantation. Transplant Proc 1991;23:547-8
19. Bolling SF, Kunkel SL, Lin H: Prolongation of cardiac allograft survival in rats by anti-TNF and cyclosporine combination therapy. Transplantation 1992;53:283-6
20. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B: The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 1992;90:693-8
21. Kapadia S, Lee JR, Torre-Amione G, Birdsall HH, Ma TS, Mann DL: Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995;96:1042-52
22. Arbustini E, Grasso M, Diegoli M, Bramerio M, Foglieni AS, Albertario M, Martinelli L, Gavazzi A, Goggi C, Campana C, Vigano M: Expression of tumor necrosis factor in human acute cardiac rejection: an immunohistochemical and immunoblotting study. Am J Pathol 1991; 139:709-15
23. Pizarro TT, Malinowska K, Kovacs EJ, Clancy J, Robinson JA, Piccinini LA: Induction of TNF-alpha and TNF-beta gene expression in rat cardiac transplants during allograft rejection. Transplantation 1993;56:399-404
24. Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Maatsa M, Mohr R, Yakirevich V: Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and perfusion. J Am Coll Cardiol 1996;28:247-52
25. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL: Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-11
26. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM: Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996;347: 1151-5
27. Gulick J, Subramaniam A, Neumann J, Robbins J: Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 1991;266:9180-5
28. Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A: Purification of cachectin, a lipoprotein lipase-suppressing hormone, secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985;161:984-95
29. Fransen L, Müller R, Marmenout A, Tavernier J, Van der Heyden J, Kawashima E, Chollet A, Tizard R, Van Heuverswyn H, Van Vliet A, Ruysschaert M-R, Fiers W: Molecular cloning of mouse tumor necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res 1985;13:4417-29
30. Semon D, Kawashima E, Jongeneel CV, Shakhov AN, Nedospasov SA: Nucleotide sequence of the murine TNF locus, including the TNF-α (tumor necrosis factor) and TNF-β (lymphotoxin) genes. Nucleic Acids Res 1987;15: 9083-4
31. Hogan B, Beddington R, Constantini F, Lacy E: Production of transgenic mice. In Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Plainview, NY, 1994, pp. 217-52
32. Gross-Bellard M, Oudet P, Chambon P: Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 1973;36:32-8
33. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9
34. Sabath DE, Broome HE, Prystowsky MB: Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 1990;91:185-91
35. Ng WA, Grupp IL, Subramaniam A, Robbins J: Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res 1991;69:1742-50
36. 2-adrenergic receptor. Science 1994;264:582-6
37. Shaw G, Kamen R: A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986;46:659-67
38. Han J, Brown T, Beutler B: Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990;171:465-75
39. Miyazaki Y, Araki K, Vesin C, Garcia I, Kapanci Y, Whitsett JA, Piguet P-F, Vassalli P: Expression of a tumor necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis: a mouse model of progressive pulmonary fibrosis. J Clin Invest 1995;96:250-9
40. Yu Z, Redfern CS, Fishman GI: Conditional transgene expression in the heart. Circ Res 1996;79:691-7
41. Wride MA, Sanders EJ: Potential roles for tumor necrosis factor áduring embryonic development. Anat Embryol 1995;191:1-10
42. Kohchi C, Koguchi K, Tanabe Y, Mizuno D, Soma G: Con-stitutive expression of TNF-α and -β genes in mouse embryo: roles of cytokine as regulator and effector on development. Int J Biochem 1994;26:111-9
43. Spach MS, Barr RC, Jewett PH: Spread of excitation from the atrium into thoracic veins in human beings and dogs. Am J Cardiol 1972;30:844-54
44. Favaro G: I1 miocardio polmonare: contributi all 'istologia umana e comparata dei vasi polmonari. Int Monatschr Anat Physiol 1910;27:375-407
45. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J: Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 1991;266:24613-20
46. Mann DL, Young JB: Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 1994;105:897-904
47. Packer M: Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 1995;92:1379-82
48. Tracey KJ: Repairing the broken heart of dilated cardiomyopathy. Lancet 1996;347:1129-30